Juan Camilo Arjona Ferreira
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Juan Camilo Arjona Ferreira
The proxy statement of Organon & Co. reports total compensation of $3,822,487 for Juan Camilo Arjona Ferreira in fiscal 2025, including a base salary of $734,615. Disclosed compensation is on record for 2 fiscal years. Juan Camilo Arjona Ferreira has spoken on 1 earnings call across 1 company, most recently for Organon & Co. on February 12, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organon & Co. (OGN)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Organon & Co.
Other people whose current roles at this company are on record from its filings.
- Joseph Morrissey CEO
- Kevin Ali CEO
- Carrie S. Cox Chairman, Board Member
- Matthew Walsh CFO
- Rachel Stahler CIO
- Kirke Weaver General Counsel
- Alan Ezekowitz, M.D., Ph.D. Board Member
- Cynthia M. Patton Board Member
- Deborah Leone Board Member
- Deborah R. Leone Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Organon & Co. (OGN) | EVP and Head of R&D and Chief Medical Officer | $734,615 | $3,822,487 |
| 2024 | Organon & Co. (OGN) | EVP and Head of R&D and Chief Medical Officer | $650,000 | $3,599,751 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.